The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALEXANDERS INC | COM | 014752109 | 7,488,631 | 38,651 | SH | DFND | 1,2 | 38,651 | 0 | 0 | |
AMPLIFY ENERGY CORP NEW | COM | 03212B103 | 17,596,646 | 2,561,375 | SH | DFND | 1,2,3,4 | 2,561,375 | 0 | 0 | |
EXELA TECHNOLOGIES INC | 6% CONV PFD SR B | 30162V607 | 230,944 | 77,498 | SH | DFND | 1,2 | 77,498 | 0 | 0 | |
EYENOVIA INC | COM | 30234E104 | 1,933,759 | 547,807 | SH | DFND | 1,2 | 547,807 | 0 | 0 | |
FORGE GLOBAL HOLDINGS INC | COM | 34629L103 | 440,139 | 251,508 | SH | DFND | 1,2 | 251,508 | 0 | 0 | |
FRONTIER COMMUNICATIONS PARE | COM | 35909D109 | 8,139,205 | 357,453 | SH | DFND | 1,2 | 357,453 | 0 | 0 | |
IMPEL PHARMACEUTICALS INC | COM | 45258K109 | 571,661 | 408,329 | SH | DFND | 1,2 | 408,329 | 0 | 0 | |
RANI THERAPEUTICS HLDGS INC | COM CL A | 753018100 | 324,497 | 62,887 | SH | DFND | 1,2 | 62,887 | 0 | 0 | |
SITIO ROYALTIES CORP | CLASS A COM | 82983N108 | 13,757,388 | 608,734 | SH | DFND | 1,2,3,4 | 608,734 | 0 | 0 | |
VNET GROUP INC | NOTE 2/0 | 90138VAB3 | 1,580,000 | 2,000,000 | SH | DFND | 1,2 | 2,000,000 | 0 | 0 |